Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies

KJM has received honoraria from Janssen, LEO Pharma, Lilly and Novartis. ADB consults lectures for Abbvie, Amgen, Boehringer Ingelheim, Celgene, Lilly, Novartis Pfizer. JNWN advisory boards at sponsored symposia together with grants research in the past 5 years AbbVie, Novartis, CEK and/or funding Galderma, GSK-Stiefel, Johnson & Johnson, Pfizer UCB Pharma. KM CEMG Actelion, Almirall, MSD, Pfizer, Sandoz, Sun Pharmaceuticals NJR reports PSORT industrial partners as listed (http://www.psort.org.uk/); other GSK-Stiefel Novartis; income to Newcastle University Sanofi Genzyme Regeneron Pharma Ltd lectures/attendance boards. All authors (ML; HA; MMS; ACG; ADO) declare no conflicts. Data presented this paper can be made available by application. Please follow steps under ‘Data Requests’ on BADBIR website: http://www.badbir.org/Publications/.